China National Accord Medicines Corp Ltd Strategic Asset Allocation Index
China National Accord Medicines Corp Ltd strategic asset allocation index. China National Accord Medicines Corp Ltd (200028) has a Strategic Asset Allocation Index of 17.5% as of September 2023. Strategic assets (PP&E of HK$3.58 Billion plus long-term investments of HK$-) total HK$3.58 Billion, measured against net assets of HK$20.47 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See 200028 equity to assets ratio to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of China National Accord Medicines Corp Ltd (2015–2022)
Strategic asset allocation index of China National Accord Medicines Corp Ltd from 2015 to 2022. This chart shows how China National Accord Medicines Corp Ltd's Strategic Asset Allocation Index has evolved across 8 annual periods from 2015 to 2022. As of September 2023, the index stands at 17.5%, representing strategic assets of HK$3.58 Billion against net assets of HK$20.47 Billion HKD. Check 200028 tangible net assets ratio to evaluate the tangible quality of the company's equity base.
China National Accord Medicines Corp Ltd Strategic Asset Allocation Index by Year (2015–2022)
China National Accord Medicines Corp Ltd strategic asset allocation index by year from 2015 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for China National Accord Medicines Corp Ltd from 2015 to 2022, covering 8 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see China National Accord Medicines Corp Ltd stock valuation.
| Year | SAAI | Strategic Assets (HKD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 17.5% | HK$3.41 Billion | HK$3.41 Billion | HK$- | HK$19.44 Billion | ▼ -1.9 pp |
| 2021 | 19.4% | HK$3.49 Billion | HK$3.49 Billion | HK$- | HK$18.02 Billion | ▲ +0.1 pp |
| 2020 | 19.3% | HK$3.26 Billion | HK$3.26 Billion | HK$- | HK$16.89 Billion | ▲ +1.5 pp |
| 2019 | 17.8% | HK$2.73 Billion | HK$2.73 Billion | HK$- | HK$15.36 Billion | ▼ -1.5 pp |
| 2018 | 19.3% | HK$2.68 Billion | HK$644.35 Million | HK$2.03 Billion | HK$13.91 Billion | ▼ -3.3 pp |
| 2017 | 22.6% | HK$2.24 Billion | HK$574.66 Million | HK$1.66 Billion | HK$9.93 Billion | ▲ +0.6 pp |
| 2016 | 22.0% | HK$1.96 Billion | HK$534.07 Million | HK$1.43 Billion | HK$8.91 Billion | ▼ -9.7 pp |
| 2015 | 31.7% | HK$1.77 Billion | HK$1.57 Billion | HK$192.96 Million | HK$5.57 Billion | — |